Some people may notice benefits within a few weeks, while others may require several months of consistent use
It reduces hunger, slows stomach emptying, and helps regulate blood sugar levels, making you feel full longer and reducing food intake without constant effort
Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: a systematic review and meta-analysis
Currently: Wegovy is FDA-approved for chronic weight management Zepbound is FDA-approved for chronic weight management in adults with obesity or overweight plus at least one weight-related condition Ozempic is FDA-approved for type 2 diabetes, not obesity From a patient perspective, FDA indication can affect insurance coverage, cost, and availability
In a clear attempt to make the price tag of GLP-1 drugs more palatable, drugmakers are promoting their other health advantages